In further stratified analysis, significantly elevated breast cancer risk was observed in BRCA2 mutation carriers (recessive model: OR = 4.88, 95% CI = 1.10–21.67; additive model: OR = 4.92, 95% CI = 1.11–21.83). The gene discussed is BRCA2; the disease is breast carcinoma.